Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Biocon Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	532523
ISIN Demat	INE376G01013
Book Value	118.98

NSE Code	BIOCON
Dividend Yield %	0.14
Market Cap	480705.27

P/E	80.10
EPS	4.49
Face Value	5


	BSE		NSE

18-Sep-2025 09:31

Last Price	361.30
Net Change	6.9
% Change	1.95%
Prev.Close	354.40
Open	359.00
High	362.00
Low	358.10
Volume	106566

Last Price	358.95
Net Change	4.6
% Change	1.3%
Prev.Close	354.35
Open	359.80
High	361.00
Low	358.40
Volume	767369

Value	38502295.8
Best Buy	361.20
Best Sell	361.40
Best Quantity	36
Sell Quantity	32
Today's Range	362.00
52-Week High	405.90
52-Week Low	290.80

Value	275447102.55
Best Buy	358.75
Best Sell	358.95
Best Quantity	430
Sell Quantity	629
Today's Range	361.00
52-Week High	406.00
52-Week Low	291.00

Open Price	359.00
High Price	362.85
Low Price	358.80
Last Price	361.65
Prev Close	356.00
Change	5.65
% Change	1.59 %

Average Price	360.74
Underlying Value	358.95
Number of contracts traded	1331
Turnover in Rs. Lakhs	12004
Open Interest	39247500.00
Change in O I	697500.00
% Change in O I	1.81 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	36
Price	361.20

Quantity	32
Price	361.40

Best Bid

Best Offer

Quantity	430
Price	358.75

Quantity	629
Price	358.95

Best Bid

Best Offer

Quantity	5000
Price	361.45

Quantity	2500
Price	361.7

Holding Details

Latest Corporate Events

Bonus

1 : 1

12-Jun-19

Book Closure

22-Jul-17

28-Jul-17

Dividend

10 %

04-Jul-25

Company News

11-09-2025

Biocon inaugurates first ...

11-09-2025

Biocon informs about pre...

11-09-2025

Biocon gains on inaugurat...

05-09-2025

USFDA completes routine c...

05-09-2025

Biocon trades higher on t...

28-08-2025

Biocon’s arm receives ten...

28-08-2025

Biocon inches up as its a...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.